| Year |
Citation |
Score |
| 2025 |
Wojcik J, Sikorski T, Wang J, Huang Y, Sugimoto H, Baratta M, Ciccimaro E, Green R, Jian W, Kar S, Kim YJ, Lassman M, Mohapatra S, Qian M, Rosenbaum AI, ... ... Yuan L, et al. 2024 White Paper on Recent Issues in Bioanalysis: Three Way-Cross Validation; Urine Clinical Analysis; Automated Methods; Regulatory Queries on Plasma Protein Binding; Automated Biospecimen Management; ELN Migration; Ultra-Sensitivity Mass Spectrometry ( - Recommendations on Advanced Strategies for Mass Spectrometry Assays, Chromatography, Sample Preparation and BMV/Regulated Bioanalysis - Regulatory Agencies' Inputs on Regulated Bioanalysis/BMV). Bioanalysis. 1-39. PMID 39862144 DOI: 10.1080/17576180.2025.2450194 |
0.577 |
|
| 2024 |
Baratta M, Jian W, Hengel S, Kaur S, Cunliffe J, Boer J, Hughes N, Kar S, Kellie J, Kim YJ, Lassman M, Mehl J, Morgan L, Palandra J, Sarvaiya H, ... ... Yuan L, et al. 2023 White Paper on Recent Issues in Bioanalysis: Deuterated Drugs; LNP; Tumor/FFPE Biopsy; Targeted Proteomics; Small Molecule Covalent Inhibitors; Chiral Bioanalysis; Remote Regulatory Assessments; Sample Reconciliation/Chain of Custody - Recommendations on Mass Spectrometry, Chromatography, Sample Preparation Latest Developments, Challenges, and Solutions and BMV/Regulated Bioanalysis - Regulatory Agencies' Inputs on Regulated Bioanalysis/BMV, Biomarkers/IVD/CDx/BAV, Immunogenicity, Gene & Cell Therapy and Vaccine). Bioanalysis. 16: 307-364. PMID 38913185 DOI: 10.1080/17576180.2024.2347153 |
0.568 |
|
| 2023 |
Szapacs M, Jian W, Spellman D, Cunliffe J, Verburg E, Kaur S, Kellie J, Li W, Mehl J, Qian M, Qiu X, Sirtori FR, Rosenbaum AI, Sikorski T, Surapaneni S, ... ... Yuan L, et al. 2022 White Paper on Recent Issues in Bioanalysis: ICH M10 BMV Guideline & Global Harmonization; Hybrid Assays; Oligonucleotides & ADC; Non-Liquid & Rare Matrices; Regulatory Inputs ( - Recommendations on Mass Spectrometry, Chromatography and Sample Preparation, Novel Technologies, Novel Modalities, and Novel Challenges, ICH M10 BMV Guideline & Global Harmonization - Regulatory Agencies' Inputs on Regulated Bioanalysis/BMV, Biomarkers/CDx/BAV, Immunogenicity, Gene & Cell Therapy and Vaccine). Bioanalysis. PMID 37650500 DOI: 10.4155/bio-2023-0167 |
0.561 |
|
| 2020 |
Zhao Y, Gu H, Postelnek J, DeMichele M, Yuan L, Zhang YJ, Zeng J. Fit-for-purpose protein biomarker assay validation strategies using hybrid immunocapture-liquid chromatography-tandem-mass spectrometry platform: Quantitative analysis of total soluble cluster of differentiation 73. Analytica Chimica Acta. 1126: 144-153. PMID 32736718 DOI: 10.1016/J.Aca.2020.06.023 |
0.37 |
|
| 2020 |
Yuan L, Sophia Xu X, Ji QC. Challenges and recommendations in developing LC-MS/MS bioanalytical assays of labile glucuronides and parent compounds in the presence of glucuronide metabolites. Bioanalysis. PMID 32441529 DOI: 10.4155/Bio-2020-0055 |
0.313 |
|
| 2019 |
Yuan L, Gu H, Zeng J, Pillutla RC, Ji QC. Application of in-sample calibration curve methodology for regulated bioanalysis: Critical considerations in method development, validation and sample analysis. Journal of Pharmaceutical and Biomedical Analysis. 177: 112844. PMID 31491659 DOI: 10.1016/J.Jpba.2019.112844 |
0.37 |
|
| 2018 |
Yuan L, Huang C, Liu-Kreyche P, Voronin K, Fancher RM, Allentoff A, Zheng N, Iyer R, Zhu L, Pillutla R, Ji QC. A convenient strategy to overcome interference in LC-MS/MS analysis: Application in a microdose absolute bioavailability study. Journal of Pharmaceutical and Biomedical Analysis. 165: 198-206. PMID 30553110 DOI: 10.1016/J.Jpba.2018.12.014 |
0.369 |
|
| 2018 |
Yuan L, Basdeo S, Ji QC. Overcoming the stability, solubility and extraction challenges in reversed-phase UHPLC-MS/MS bioanalysis of a phosphate drug and its prodrug in blood lysate. Journal of Pharmaceutical and Biomedical Analysis. 157: 36-43. PMID 29758468 DOI: 10.1016/J.Jpba.2018.05.006 |
0.372 |
|
| 2018 |
Yuan L, Ji QC. Discovery, identification and mitigation of isobaric sulfate metabolite interference to a phosphate prodrug in LC-MS/MS bioanalysis: Critical role of method development in ensuring assay quality. Journal of Pharmaceutical and Biomedical Analysis. 155: 141-147. PMID 29631074 DOI: 10.1016/J.Jpba.2018.03.064 |
0.37 |
|
| 2016 |
Yuan L, Ma L, Dillon L, Fancher RM, Sun H, Zhu M, Lehman-McKeeman L, Aubry AF, Ji QC. Investigation of the "true" extraction recovery of analytes from multiple types of tissues and its impact on tissue bioanalysis using two model compounds. Analytica Chimica Acta. 945: 57-66. PMID 27968716 DOI: 10.1016/J.Aca.2016.09.039 |
0.341 |
|
| 2016 |
Yuan L, Luo Y, Kandoussi H, Ji QC. A simple, fast, sensitive and robust LC-MS/MS bioanalytical assay for evaluating 7α-hydroxy-4-cholesten-3-one biomarker in a clinical program. Bioanalysis. 8: 2445-2455. PMID 27855505 DOI: 10.4155/Bio-2016-0219 |
0.336 |
|
| 2016 |
Yuan L, Aubry AF, Ji QC. A simple, effective approach for rapid development of high-throughput and reliable LC-MS/MS bioanalytical assays. Bioanalysis. PMID 27491843 DOI: 10.4155/Bio-2016-0100 |
0.367 |
|
| 2015 |
Yuan L, Schuster A, Shen JX, Garrison-Borowski P, Aubry AF. Dried blood spot analysis without dilution: Application to the LC-MS/MS determination of BMS-986001 in rat dried blood spot. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 1002: 201-9. PMID 26340763 DOI: 10.1016/J.Jchromb.2015.08.029 |
0.356 |
|
| 2015 |
Liu J, Yuan L, Liu G, Shen JX, Aubry AF, Arnold ME, Ji QC. A UHPLC-MS/MS bioanalytical assay for the determination of BMS-911543, a JAK2 inhibitor, in human plasma. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 991: 85-91. PMID 25930207 DOI: 10.1016/J.Jchromb.2015.04.013 |
0.534 |
|
| 2015 |
Zheng N, Yuan L, Ji QC, Mangus H, Song Y, Frost C, Zeng J, Aubry AF, Arnold ME. "Center punch" and "whole spot" bioanalysis of apixaban in human dried blood spot samples by UHPLC-MS/MS. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 988: 66-74. PMID 25746754 DOI: 10.1016/J.Jchromb.2015.02.023 |
0.362 |
|
| 2014 |
Yuan L, Jiang H, Zheng N, Xia YQ, Ouyang Z, Zeng J, Akinsanya B, Valentine JL, Moehlenkamp JD, Deng Y, Aubry AF, Arnold ME. A validated LC-MS/MS method for the simultaneous determination of BMS-791325, a hepatitis C virus NS5B RNA polymerase inhibitor, and its metabolite in plasma. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 973: 1-8. PMID 25464088 DOI: 10.1016/J.Jchromb.2014.10.005 |
0.364 |
|
| 2014 |
Yuan L, Fu Y, Zhang D, Xia YQ, Peng Q, Aubry AF, Arnold ME. Use of a carboxylesterase inhibitor of phenylmethanesulfonyl fluoride to stabilize epothilone D in rat plasma for a validated UHPLC-MS/MS assay. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 969: 60-8. PMID 25151331 DOI: 10.1016/J.Jchromb.2014.08.006 |
0.369 |
|
| 2014 |
Yuan L, Mai A, Aubry AF, Arnold ME, Ji QC. Feasibility assessment of a novel selective peptide derivatization strategy for sensitivity enhancement for the liquid chromatography/tandem mass spectrometry bioanalysis of protein therapeutics in serum. Rapid Communications in Mass Spectrometry : Rcm. 28: 705-12. PMID 24573801 DOI: 10.1002/Rcm.6836 |
0.311 |
|
| 2014 |
Yuan L, Jian W, Zhang D, Aubry AF, Arnold ME. Application of a stabilizer cocktail of N-ethylmaleimide and phenylmethanesulfonyl fluoride to concurrently stabilize the disulfide and ester containing compounds in a plasma LC-MS/MS assay. Journal of Pharmaceutical and Biomedical Analysis. 88: 552-61. PMID 24211707 DOI: 10.1016/J.Jpba.2013.10.014 |
0.377 |
|
| 2013 |
Yuan L, Aubry AF, Arnold ME, Ji QC. Systematic investigation of orthogonal SPE sample preparation for the LC-MS/MS bioanalysis of a monoclonal antibody after pellet digestion. Bioanalysis. 5: 2379-91. PMID 24066623 DOI: 10.4155/Bio.13.224 |
0.344 |
|
| 2013 |
Yuan L, Jiang H, Ouyang Z, Xia YQ, Zeng J, Peng Q, Lange RW, Deng Y, Arnold ME, Aubry AF. A rugged and accurate liquid chromatography-tandem mass spectrometry method for the determination of asunaprevir, an NS3 protease inhibitor, in plasma. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 921: 81-6. PMID 23435345 DOI: 10.1016/J.Jchromb.2013.01.029 |
0.364 |
|
| 2013 |
Zhao Y, Liu G, Liu Y, Yuan L, Hawthorne D, Shen JX, Guha M, Aubry A. Improved ruggedness of an ion-pairing liquid chromatography/tandem mass spectrometry assay for the quantitative analysis of the triphosphate metabolite of a nucleoside reverse transcriptase inhibitor in peripheral blood mononuclear cells. Rapid Communications in Mass Spectrometry : Rcm. 27: 481-8. PMID 23280981 DOI: 10.1002/Rcm.6473 |
0.501 |
|
| 2012 |
Yuan L, Arnold ME, Aubry AF, Ji QC. Simple and efficient digestion of a monoclonal antibody in serum using pellet digestion: comparison with traditional digestion methods in LC-MS/MS bioanalysis. Bioanalysis. 4: 2887-96. PMID 23244280 DOI: 10.4155/Bio.12.284 |
0.333 |
|
| 2012 |
Yuan L, Zhang D, Jemal M, Aubry AF. Systematic evaluation of the root cause of non-linearity in liquid chromatography/tandem mass spectrometry bioanalytical assays and strategy to predict and extend the linear standard curve range. Rapid Communications in Mass Spectrometry : Rcm. 26: 1465-74. PMID 22592990 DOI: 10.1002/Rcm.6252 |
0.351 |
|
| 2011 |
van Breemen RB, Sharifi R, Viana M, Pajkovic N, Zhu D, Yuan L, Yang Y, Bowen PE, Stacewicz-Sapuntzakis M. Antioxidant effects of lycopene in African American men with prostate cancer or benign prostate hyperplasia: a randomized, controlled trial. Cancer Prevention Research (Philadelphia, Pa.). 4: 711-8. PMID 21430075 DOI: 10.1158/1940-6207.Capr-10-0288 |
0.593 |
|
| 2009 |
Wang Z, Wijewickrama GT, Peng KW, Dietz BM, Yuan L, van Breemen RB, Bolton JL, Thatcher GR. Estrogen Receptor {alpha} Enhances the Rate of Oxidative DNA Damage by Targeting an Equine Estrogen Catechol Metabolite to the Nucleus. The Journal of Biological Chemistry. 284: 8633-42. PMID 19158089 DOI: 10.1074/Jbc.M807860200 |
0.435 |
|
| 2006 |
Kapetanovic IM, Krishnaraj R, Martin-Jimenez T, Yuan L, van Breemen RB, Lyubimov A. Effects of oral dosing paradigms (gavage versus diet) on pharmacokinetics and pharmacodynamics. Chemico-Biological Interactions. 164: 68-75. PMID 17027946 DOI: 10.1016/J.Cbi.2006.08.019 |
0.462 |
|
| Show low-probability matches. |